Work

Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.

Year: 2009

Type: article

Source: PubMed

Authors: Leigh D Church, Michael F McDermott

Institution: St James's University Hospital

Language: English

Topic: Inflammasome and immune disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2432418760

FWCI: 4.663

Cites:

Cited by: 109

Related to: 10